Stock-Based Compensation

3 Months Ended

Mar. 31, 2020

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

We recognized total stock-based compensation expense in our Condensed Consolidated Statements of Operations as follows (in thousands):


	Three months ended March 31,
	2020		2019
Cost of goods sold	$	761	$	820
Research and development	15,453		16,623
General and administrative	7,997		7,942
Impairment of assets and other costs for terminated program	1,025		$	—
Total stock-based compensation	$	25,236	$	25,385

The stock-based compensation expense reported in impairment of assets and other costs for terminated program results from executive severance, which we are currently accounting for as a liability award. However, we expect to settle this award in stock in the second quarter of 2020.

We issued stock-based awards and resulting shares of our common stock as follows (shares in thousands):


	Three months ended March 31,
	2020		2019
Options granted	49		20
Weighted-average grant-date fair value of options granted	$	11.88	$	25.51
RSUs granted	245		133
Weighted-average grant-date fair value of RSUs granted	$	18.91	$	40.95
Shares issued under equity compensation plans	1,358		698